LDL-C-lowering therapies reduce major vascular events in patients aged ≥75 y.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 33819068.
- Also identified by DOI 10.7326/ACPJ202104200-038.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gencer B, Marston NA, Im K, et al. <b>Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials.</b> Lancet. 2020;396:1637-43. 33186535.
Medical subject headings
- Anticholesteremic Agents
- Cardiovascular Diseases
- Hydroxymethylglutaryl-CoA Reductase Inhibitors